Showing results (21-30 of 102) with videos related to
Sort By:
Pageof 11
Pharmacology, Biochemistry, and Behavior|May 1, 1985
Comparison of anorexia and motor disruption by cyclazocine and quipazineJ W Henck, D H Rezabek, R H RechRespiration; International Review of Thoracic Diseases|June 14, 2017
Fatigue and Excessive Daytime Sleepiness in Sarcoidosis: Prevalence, Predictors, and Relationships between the Two SymptomsAndrea Bosse-Henck, Rainer Koch, Hubert Wirtz, et al.Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|February 1, 1992
Developmental toxicity of CI-921, an anilinoacridine antitumor agentJ W Henck, S L Brown, J A AndersonToxicological Sciences : an Official Journal of the Society of Toxicology|June 16, 2001
Growth and development in rats given recombinant human epidermal growth factor(1-48) as neonatesJ W Henck, J F Reindel, J A AndersonDrug and Chemical Toxicology|January 1, 1980
Skin sensitization potential of trisodium ethylenediaminetetraacetateJ W Henck, D D Lockwood, K J OlsonDrug and Chemical Toxicology|January 1, 1982
Subchronic dermal toxicity study of trichlorobenzene in the rabbitK S Rao, K A Johnson, J W HenckBMC Neuroscience|January 8, 2017
CX3C chemokine receptor 1 deficiency modulates microglia morphology but does not affect lesion size and short-term deficits after experimental strokeGerlinde van der Maten, Vivien Henck, Tadeusz Wieloch, et al.Pharmacology, Biochemistry, and Behavior|January 1, 1983
Cyclazocine disruption of operant behavior is antagonized by naloxone and metergolineJ W Henck, D J Mokler, R L Commissaris, et al.Respiratory Care|November 21, 2013
Factors associated with fatigue in sarcoidosisMichael Fleischer, Andreas Hinz, Elmar Brähler, et al.The Journal of Pharmacology and Experimental Therapeutics|April 16, 2017
Relief of Pain-Depressed Behavior in Rats by Activation of D1-Like Dopamine ReceptorsMatthew F Lazenka, Kelen C Freitas, Sydney Henck, et al.Pageof 11